RT Book, Section
A1 Bates, Susan E.
A1 Von Hoff, Daniel D.
A2 Boyiadzis, Michael M.
A2 Fojo, Tito
SR Print(0)
ID 1187884446
T1 Pancreatic Cancer
T2 Hematology-Oncology Therapy, 3e
YR 2022
FD 2022
PB McGraw-Hill Education
PP New York, NY
SN 9781260117400
LK hemonc.mhmedical.com/content.aspx?aid=1187884446
RD 2024/04/20
AB EpidemiologyTable  Graphic  Jump  Location|Download  (.pdf)|PrintEpidemiologyIncidence3.2%  of  all  new  cancer  casesEstimated  new  cases  for  2019  in  the  United  States:  56,770  (male:  29,940;  female:  26,830)12.6  per  100,000  men  and  womenDeathsEstimated  57,600  in  2020  (male:  30,400;  female:  27,200)Median  age70  yearsMale  to  female  ratio~1:1  Stage  at  presentationStage  I:10%  Stage  II:22%  Stage  III:13%  Stage  IV:55%  Location  at  Presentation  and  Surgical  ResectionLocationPercent  of  all  presentationsPercent  amenable  to  surgical  resection  at  each  disease  siteHead  of  pancreas67%27.9%Pancreas  body16%10.7%Tail  of  pancreas17%17%  Surgical  resectionOverall  25%  of  patients  undergo  surgerySurvival5-year  survival,  all  patients  =  9.3%5-year  survival  following  resection  =  25%Bilimoria  et  al.  Cancer  2007;110:1227–1234Huang  L  et  al.  Gut  2019;68:130–139Siegel  RL  et  al.  CA  Cancer  J  Clin  2019;69:7–34Surveillance,  Epidemiology,  and  End  Results  (SEER)  Program,  available  from  http://seer.cancer.gov  [accessed  in  2019]Winer  LK  et  al.  J  Surg  Res  2019;239:60–66